These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24021545)

  • 21. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained 3-year remission after rituximab treatment in a patient with refractory Wegener's granulomatosis.
    Tektonidou MG; Skopouli FN
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S103. PubMed ID: 16859607
    [No Abstract]   [Full Text] [Related]  

  • 23. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
    Pullerits R; Ljevak M; Vikgren J; Bokarewa M
    Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab therapy for Wegener's granulomatosis refractory to conventional treatment.
    Sánchez-Escuredo A; Núñez R; Ibernón M; Martínez E; López D; Navarro M; Bonet J; Ara J; Romero R
    Nefrologia; 2011; 31(4):502-4. PubMed ID: 21738261
    [No Abstract]   [Full Text] [Related]  

  • 25. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Mohammad AJ; Hot A; Arndt F; Moosig F; Guerry MJ; Amudala N; Smith R; Sivasothy P; Guillevin L; Merkel PA; Jayne DR
    Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical problem-solving. More than meets the ear.
    Marinopoulos SS; Coylewright M; Auwaerter PG; Flynn JA
    N Engl J Med; 2010 Apr; 362(13):1228-33. PubMed ID: 20357286
    [No Abstract]   [Full Text] [Related]  

  • 27. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis.
    Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S
    Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229
    [No Abstract]   [Full Text] [Related]  

  • 28. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
    Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flare of essential mixed cryoglobulinemic vasculitis with hemorrhagic bullous purpura after rituximab infusion.
    Zenone T
    Int J Rheum Dis; 2013 Apr; 16(2):237-9. PubMed ID: 23773652
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
    Cianchini G; Lupi F; Masini C; Corona R; Puddu P; De Pità O
    J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granulomatosis with polyangitis (Wegener's).
    Takimoto T; Morimura O; Inoue T; Terada H; Abe K
    Thorax; 2012 Jun; 67(6):563-4. PubMed ID: 20671306
    [No Abstract]   [Full Text] [Related]  

  • 32. Rituximab associated pneumonitis in antineutrophil cytoplasmic antibody-associated vasculitis.
    Arulkumaran N; Suleman R; Cecconi M; Kiely P; Chua F
    J Clin Rheumatol; 2012 Jan; 18(1):39-41. PubMed ID: 22157278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients.
    Wendt M; Gunnarsson I; Bratt J; Bruchfeld A
    Scand J Rheumatol; 2012 Mar; 41(2):116-9. PubMed ID: 22118245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients.
    Calich AL; Puéchal X; Pugnet G; London J; Terrier B; Charles P; Mouthon L; Guillevin L;
    J Autoimmun; 2014 May; 50():135-41. PubMed ID: 24703438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. S3. Rituximab for ANCA-associated vasculitides: the French experience.
    Charles P; Guillevin L
    Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207
    [No Abstract]   [Full Text] [Related]  

  • 36. [ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].
    Bakashvili N; Swaak AJ; Tervaert JW; Dees A
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):1009-14. PubMed ID: 18549177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis.
    Golbin JM; Specks U
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S74-6. PubMed ID: 17428376
    [No Abstract]   [Full Text] [Related]  

  • 38. Severe multi-resistant pemphigus vulgaris: prolonged remission with a single cycle of rituximab.
    Corral IS; Freitas TH; Aquino RT; Koller DA; Magliari ME; Muller H
    An Bras Dermatol; 2013; 88(4):639-42. PubMed ID: 24068143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Otolaryngological progression of granulomatosis with polyangiitis after systemic treatment with rituximab.
    Malm IJ; Mener DJ; Kim J; Seo P; Kim YJ
    Otolaryngol Head Neck Surg; 2014 Jan; 150(1):68-72. PubMed ID: 24154746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanded spectrum of antineutrophil cytoplasmic antibody-negative vasculitis involving vessels from capillaries to medium-sized arteries.
    Qian Q; Thanarajasingam U; Oeckler RA; Sawyer MD; Sethi S; Edwards WD
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1634-8. PubMed ID: 22034125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.